Abstract
This review strengthens the argument that complete surgical resection of soft-tissue sarcoma pulmonary metastases provides the best chance of cure in patients with soft-tissue sarcoma metastatic to the lungs. The use of prognostic indicators in selecting appropriate surgical candidates remains an inexact science but should be used in developing novel multidisciplinary treatment therapies. Surgery does not affect the biology of the disease but should be used to understand the biology of metastasis in an effort to better define alterations at the molecular level that may lead to novel treatment strategies.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 843-844 |
| Number of pages | 2 |
| Journal | ONCOLOGY |
| Volume | 14 |
| Issue number | 6 |
| State | Published - Dec 1 2000 |
ASJC Scopus subject areas
- Oncology
- Cancer Research